- Home
- KEP vs RVMD Comparison
KEP vs RVMD Comparison
Compare KEP & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEP
- RVMD
- Stock Information
- Founded
- KEP 1961
- RVMD 2014
- Country
- KEP South Korea
- RVMD United States
- Employees
- KEP N/A
- RVMD N/A
- Industry
- KEP Electric Utilities: Central
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KEP Utilities
- RVMD Health Care
- Exchange
- KEP Nasdaq
- RVMD Nasdaq
- Market Cap
- KEP 9.9B
- RVMD 8.7B
- IPO Year
- KEP N/A
- RVMD 2020
- Fundamental
- Price
- KEP $7.14
- RVMD $44.06
- Analyst Decision
- KEP
- RVMD Strong Buy
- Analyst Count
- KEP 0
- RVMD 12
- Target Price
- KEP N/A
- RVMD $64.67
- AVG Volume (30 Days)
- KEP 297.7K
- RVMD 2.2M
- Earning Date
- KEP 12-31-2024
- RVMD 11-06-2024
- Dividend Yield
- KEP N/A
- RVMD N/A
- EPS Growth
- KEP N/A
- RVMD N/A
- EPS
- KEP 4.40
- RVMD N/A
- Revenue
- KEP $70,353,349,144.00
- RVMD $742,000.00
- Revenue This Year
- KEP $5.44
- RVMD N/A
- Revenue Next Year
- KEP $3.10
- RVMD $1,855.42
- P/E Ratio
- KEP $3.19
- RVMD N/A
- Revenue Growth
- KEP 8.48
- RVMD N/A
- 52 Week Low
- KEP $6.69
- RVMD $25.93
- 52 Week High
- KEP $9.55
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- KEP 33.30
- RVMD 32.07
- Support Level
- KEP $7.31
- RVMD $44.50
- Resistance Level
- KEP $7.57
- RVMD $46.15
- Average True Range (ATR)
- KEP 0.14
- RVMD 1.89
- MACD
- KEP -0.08
- RVMD -0.58
- Stochastic Oscillator
- KEP 8.39
- RVMD 19.95
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.